Tempus gets FDA clearance for pulmonary hypertension AI
- Tempus AI (TEM) said it received FDA 510(k) clearance for an AI-enabled software device that analyzes standard 12-lead ECGs for signs associated with pulmonary hypertension.
- The clearance adds pulmonary hypertension to Tempus’ FDA-cleared cardiovascular AI products for atrial fibrillation and low
How it works
Once you click Generate, Ollama reads this article and crafts 5 comprehension questions. Your answers are graded against the article content — general knowledge won't be enough. Score 70+ to count toward your certificate.
Questions are cached — you'll always get the same 5 for this article.